Search

Your search keyword '"Ward, Jeffrey"' showing total 852 results

Search Constraints

Start Over You searched for: Author "Ward, Jeffrey" Remove constraint Author: "Ward, Jeffrey"
852 results on '"Ward, Jeffrey"'

Search Results

3. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy

13. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

14. Trends in Stage I Lung Cancer

18. Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations

22. EVEREST-2: A seamless phase 1/2 study of A2B694, a logic-gated Tmod chimeric antigen receptor T-cell (CAR T) therapy, in patients with pancreatic cancer (PANC) or other mesothelin (MSLN)-expressing solid tumors and human leukocyte antigen (HLA)&#8211...

24. Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma

26. Multiyear defoliations in southern New England increases oak mortality

29. A Dynamic Approach to Strategic Planning to Facilitate Conversation and Advocate for Your Program.

31. Admission and Assessment of Music Degree Candidates

32. Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

34. RECENT DEVELOPMENTS IN INSURANCE COVERAGE

35. cDC1 prime and are licensed by CD4.sup.+ T cells to induce anti-tumour immunity

37. Legitimacy of parole as a consequence of policy shock: The lived experiences of incarcerated persons during the parole moratorium in Pennsylvania, U.S.

38. Stormwise: Innovative Forest Management to Promote Storm Resistance in Roadside Forests.

39. Does Ten Have a Friend?

42. High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy

44. Advancing alternative methods to reduce animal testing.

45. MHC-II neoantigens shape tumour immunity and response to immunotherapy

48. Stand dynamics in Connecticut hardwood forests : the old series plots (1927-1997) /

49. 607 TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in the pivotal LUNAR study

50. 634 EVEREST-1: A seamless phase 1/2 study of CEA logic-gated Tmod CAR T-cell therapy (A2B530) in patients with solid tumors associated with CEA expression also exhibiting HLA loss of heterozygosity (LOH)

Catalog

Books, media, physical & digital resources